Background
==========

Acute myocarditis is typically diagnosed on CMR using multiple techniques, including late gadolinium enhancement (LGE) imaging, which require contrast administration. T1-mapping is significantly more sensitive than conventional T2-weighted (T2W) and LGE imaging in detecting myocarditis, without the need for contrast agents.

Methods
=======

We investigated 60 patients with suspected acute myocarditis (median 3 days from presentation) and 50 controls using CMR (1.5T), including: (1) dark-blood T2W imaging; (2) T1-mapping (ShMOLLI); (3) LGE (Figure [1](#F1){ref-type="fig"}). Analysis included: (1) global myocardial T2 signal intensity (SI) compared to skeletal muscle; (2) myocardial T1 times; (3) areas of injury by T2W, T1-mapping and LGE.

![**CMR tissue characterization using (A) dark-blood T2-weighted imaging; (B) native T1-mapping (ShMOLLI); (C) late gadolinium enhancement imaging**.](1532-429X-16-S1-O6-1){#F1}

Results
=======

Compared to controls, patients had significantly more edema (global myocardial T2 SI ratio 1.71 ± 0.27 vs.1.56 ± 0.15), higher mean myocardial T1 (1011 ± 64 ms vs. 946 ± 23 ms) and more areas of injury measured by T2 (median 5% vs. 0%), T1 (median 32% vs. 0.7%) and LGE (median 11% vs. 0%); all p \< 0.001. A threshold of T1 \> 990 ms (sensitivity 90%, specificity 91%) detected significantly larger areas of involvement than T2W and LGE imaging in patients, and additional areas of injury when T2W and LGE were negative. Using incremental thresholds, T1-mapping can display the non-ischemic patterns of injury typical of myocarditis (Figure [2](#F2){ref-type="fig"}).

![**Native T1-maps displaying the non-ischemic patterns of injury in acute myocarditis using incremental T1 thresholds**.](1532-429X-16-S1-O6-2){#F2}

Conclusions
===========

In acute myocarditis, native T1-mapping can display the typical non-ischemic patterns similar to LGE imaging without the need for contrast agents. T1-mapping also detects additional areas of involvement and identifies extra cases beyond T2W and LGE imaging.
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